1. Home
  2. ABP vs ALUR Comparison

ABP vs ALUR Comparison

Compare ABP & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • ALUR
  • Stock Information
  • Founded
  • ABP 2004
  • ALUR 2009
  • Country
  • ABP United States
  • ALUR United States
  • Employees
  • ABP N/A
  • ALUR N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • ALUR
  • Sector
  • ABP Health Care
  • ALUR
  • Exchange
  • ABP Nasdaq
  • ALUR Nasdaq
  • Market Cap
  • ABP 12.1M
  • ALUR 14.2M
  • IPO Year
  • ABP N/A
  • ALUR N/A
  • Fundamental
  • Price
  • ABP $0.27
  • ALUR $2.87
  • Analyst Decision
  • ABP Strong Buy
  • ALUR Strong Buy
  • Analyst Count
  • ABP 1
  • ALUR 3
  • Target Price
  • ABP $4.00
  • ALUR $22.83
  • AVG Volume (30 Days)
  • ABP 17.5M
  • ALUR 600.0K
  • Earning Date
  • ABP 05-22-2025
  • ALUR 05-14-2025
  • Dividend Yield
  • ABP N/A
  • ALUR N/A
  • EPS Growth
  • ABP N/A
  • ALUR N/A
  • EPS
  • ABP N/A
  • ALUR N/A
  • Revenue
  • ABP $183,000.00
  • ALUR $28,304,000.00
  • Revenue This Year
  • ABP N/A
  • ALUR N/A
  • Revenue Next Year
  • ABP N/A
  • ALUR $38.86
  • P/E Ratio
  • ABP N/A
  • ALUR N/A
  • Revenue Growth
  • ABP 50.00
  • ALUR N/A
  • 52 Week Low
  • ABP $0.23
  • ALUR $2.15
  • 52 Week High
  • ABP $13.00
  • ALUR $88.75
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • ALUR 62.51
  • Support Level
  • ABP N/A
  • ALUR $2.15
  • Resistance Level
  • ABP N/A
  • ALUR $3.42
  • Average True Range (ATR)
  • ABP 0.00
  • ALUR 0.23
  • MACD
  • ABP 0.00
  • ALUR 0.09
  • Stochastic Oscillator
  • ABP 0.00
  • ALUR 56.69

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: